TA
PGNX

Tamarack Advisers’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Tamarack Advisers’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,100,000
Closed -$4.18M – 42
2020
Q1 		$4.18M Buy
+1,100,000
New +$4.74M 1.58% 19

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Tamarack Advisers's PGNX Position: Q2 2020 in Review

Tamarack Advisers sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 1,100,000 shares — an estimated $4.18M sold.

Tamarack Advisers first reported a position in PGNX in Q1 2020 and held it in 1 quarter. The position peaked at $4.18M in Q1 2020. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Tamarack Advisers reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Tamarack Advisers sold 1,100,000 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $4.18M.
  • Tamarack Advisers first reported a position in Progenics Pharmaceuticals Inc in Q1 2020 and held it in 1 quarter.
  • Tamarack Advisers's Progenics Pharmaceuticals Inc position peaked at $4.18M in Q1 2020.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Tamarack Advisers's 13F filing for Q2 2020, filed 11 Aug 2020.